PlainRecalls
FDA Drug Moderate Class II Ongoing

Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61

Reported: October 29, 2025 Initiated: October 10, 2025 #D-0030-2026

Product Description

Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61

Reason for Recall

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

Details

Distribution
US Nationwide.
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61. Recalled by The Harvard Drug Group LLC.
Why was this product recalled?
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Which agency issued this recall?
This recall was issued by the FDA Drug on October 29, 2025. Severity: Moderate. Recall number: D-0030-2026.